Lupus anticoagulant and ischemic myocardial microangiopathy in rheumatoid arthritis (Q28218493)

4

0 references

Gianfranco Ferraccioli

object named as

Gianfranco Ferraccioli

1

0 references

author name string

Angelo Zoli

2

0 references

Alfonso Verrillo

5

0 references

Francesco Loperfido

Nature Clinical Practice Cardiovascular Medicine

6

0 references

language of work or name

English

0 references

publication date

June 2006

0 references

published in

0 references

volume

3

0 references

issue

6

0 references

page(s)

339-43; quiz following 343

0 references

cites work

Rheumatoid arthritis: a disease associated with accelerated atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0576

The lupus anticoagulant is a risk factor for myocardial infarction (but not atherosclerosis): Hopkins Lupus Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0576

Cardiac involvement in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0576

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0576

Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0576

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0576

Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0576

Autoantibodies and thrombophilia in RA: TNFalpha and TNFalpha blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0576

Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0576

High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0576

inferred from DOI database lookup

7 January 2021

based on heuristic

Renal thrombotic microangiopathy in a patient with rheumatoid arthritis and antiphospholipid syndrome: successful treatment with cyclophosphamide pulse therapy and anticoagulant.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0576